Philips Respironics Recall: Programming Errors in DreamStation Devices Highlight Patient Risks
Philips Respironics has announced the recall of certain DreamStation Auto CPAP and Auto BiPAP devices due to programming errors that
Critical Recall Update: BD Alaris™ Pump Infusion Sets Expand Warning to Higher Risks
Medical technology manufacturer BD has announced an expanded voluntary recall of certain BD Alaris™ Pump Module model 8100 infusion sets.
Voluntary Recall Issued for Olympus ViziShot 2 FLEX 19G Needles Due to Safety Concerns
Olympus Corporation has announced a voluntary global recall of specific lots of its ViziShot 2 FLEX (19G) EBUS-TBNA needles. These
FDA Unveils Groundbreaking Dashboard for Real-Time Reporting of Cosmetic Product Adverse Events
On September 30, 2025, the U.S. Food and Drug Administration (FDA) introduced a new interactive tool, the FDA Adverse Event
FDA Accelerates Approval of Forzinity: A Milestone for Barth Syndrome Treatment
The U.S. Food and Drug Administration (FDA) has taken a groundbreaking step by granting accelerated approval to Forzinity (elamipretide) injection
FDA Expands Early Alert Program for High-Risk Medical Device Recalls
On September 29, 2025, the FDA announced the expansion of its Early Alert program. This initiative is designed to improve
New Clinical Trial to Assess Safety and Efficacy of Thermage® FLX Radiofrequency for Skin Rejuvenation
Clinical testing on the Thermage® FLX device is set to evaluate its safety and effectiveness in treating skin laxity and
Pistacia Lentiscus Oil Nasal Drops: A Potential Solution for Chronic Rhinosinusitis Recurrence
Meta Description: A clinical trial evaluates Pistacia lentiscus oil nasal drops for preventing chronic rhinosinusitis recurrence. Results may impact treatment
New Advances in Drug-Eluting Stents for Intracranial Arterial Stenosis
Publication Date: October 1, 2025 Beijing Tiantan Hospital is actively recruiting participants for a groundbreaking clinical trial exploring the efficacy
EmboBio: Investigating Safety and Performance for Treating Abdominopelvic Bleeding
A newly announced clinical study is set to evaluate the safety and performance of EmboBio, an innovative medical device for